Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Br J Pharmacol ; 156(7): 1115-23, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19298391

ABSTRACT

BACKGROUND AND PURPOSE: The inflammatory cytokine interleukin-1 (IL-1) has profound actions in the brain, causing neuronal cell death and exacerbating brain damage. While circulating levels are normally low, IL-1 can be produced on the vascular side of the brain endothelium, and within the brain. The naturally occurring IL-1 receptor antagonist has been administered peripherally in a Phase II trial in acute stroke patients; understanding how IL-1 and IL-1 receptor antagonist penetrate the brain is, therefore, of considerable importance. EXPERIMENTAL APPROACH: An in vitro blood-brain barrier model was generated by co-culture of porcine brain microvascular endothelial cells with astrocytes. The mechanisms of transcellular transport of IL-1beta and IL-1 receptor antagonist were characterized in this model, using endocytosis inhibitors and IL-1 receptor-blocking antibodies. KEY RESULTS: Transcellular IL-1beta and IL-1 receptor antagonist transport was temperature-dependent and IL-1beta was transported with higher affinity than IL-1 receptor antagonist. IL-1beta inhibited IL-1 receptor antagonist transport more potently than IL-1 receptor antagonist inhibited IL-1beta transport. Transport of IL-1beta and IL-1 receptor antagonist was not via adsorptive-mediated endocytosis, although inhibition of microtubule assembly significantly attenuated transport of both cytokines. An antibody directed to the type II IL-1 receptor significantly reduced IL-1beta transport. CONCLUSIONS AND IMPLICATIONS: These results are consistent with IL-1 and IL-1 receptor antagonist being transported across cultured cerebromicrovascular endothelial cells and suggest that IL-1beta transport may occur via a type II IL-1 receptor-dependent mechanism. Understanding IL-1 transport into the brain may have benefits, particularly in enhancing penetration of IL-1 receptor antagonist into the brain.


Subject(s)
Blood-Brain Barrier/metabolism , Endothelial Cells/metabolism , Interleukin 1 Receptor Antagonist Protein/metabolism , Interleukin-1beta/metabolism , Microvessels/metabolism , Animals , Antibodies/pharmacology , Astrocytes/metabolism , Biological Transport , Brain/blood supply , Coculture Techniques , Endocytosis/drug effects , Microvessels/cytology , Receptors, Interleukin-1 Type I/antagonists & inhibitors , Receptors, Interleukin-1 Type I/immunology , Receptors, Interleukin-1 Type I/physiology , Receptors, Interleukin-1 Type II/antagonists & inhibitors , Receptors, Interleukin-1 Type II/immunology , Receptors, Interleukin-1 Type II/physiology , Swine
2.
Parasitol Int ; 49(4): 309-20, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11077265

ABSTRACT

DNA fragments homologous to members of the family of P-type ion-motive ATPases were identified in Trypanosoma cruzi by polymerase chain reaction (PCR) amplification. The sequence of one fragment, which closely resembled (87% identity) the tandemly linked proton pumps in Leishmania, was used to characterize the H(+)-ATPase genes in T. cruzi. The T. cruzi proton pump locus contains four tandemly repeated genes (TCH1-4) separated by 1.1 kb intergenic regions. The nucleotide sequence of one cloned gene of the tandem array contains a 2775 nt open reading frame encoding a predicted 101908-Da protein of 925 amino acids. The TCH genes are expressed as 3.8 and 4.9 kb polyadenylated transcripts in the epimastigote stage; expression of both transcripts is reduced in metacyclic trypomastigotes. Results of 5' and 3' RACE transcript mapping indicate that the 3.8 kb message is generated from within the tandemly repeated locus. The 3.8 kb TCH transcript has the T. cruzi mini-exon appended to a short (40 nt) 5' untranslated region (UTR) and has a 927 nt 3' UTR. The full peptide sequence of the T. cruzi proton pump is 80% identical to the Leishmania pump but lacks the extended carboxyl tail present in the Leishmania ATPase. An antibody that recognizes the 110-kDa Leishmania donovani proton pump cross-reacts with a 100-kDa protein in lysates of T. cruzi epimastigotes.


Subject(s)
Genome, Protozoan , Leishmania/enzymology , Proton Pumps/genetics , Proton-Translocating ATPases/genetics , Trypanosoma cruzi/enzymology , Amino Acid Sequence , Animals , Base Sequence , Blotting, Western , Chromosome Mapping , Cloning, Molecular , Leishmania/genetics , Molecular Sequence Data , Proton Pumps/metabolism , Proton-Translocating ATPases/metabolism , Sequence Alignment , Sequence Analysis, DNA , Transcription, Genetic , Trypanosoma cruzi/genetics
3.
J Biol Chem ; 274(11): 7272-7, 1999 Mar 12.
Article in English | MEDLINE | ID: mdl-10066789

ABSTRACT

Asexual stages of Plasmodium falciparum cause severe malaria and are dependent upon host glucose for energy. We have identified a glucose transporter of P. falciparum (PfHT1) and studied its function and expression during parasite development in vitro. PfHT1 is a saturable, sodium-independent, and stereospecific transporter, which is inhibited by cytochalasin B, and has a relatively high affinity for glucose (Km = 0.48 mM) when expressed in Xenopus laevis oocytes. Competition experiments with glucose analogues show that hydroxyl groups at positions C-3 and C-4 are important for ligand binding. mRNA levels for PfHT1, assessed by the quantitative technique of tandem competitive polymerase chain reaction, are highest during the small ring stages of infection and lowest in gametocytes. Confocal immunofluorescence microscopy localizes PfHT1 to the region of the parasite plasma membrane and not to host structures. These findings have implications for development of new drug targets in malaria as well as for understanding of the pathophysiology of severe infection. When hypoglycemia complicates malaria, modeling studies suggest that the high affinity of PfHT1 is likely to increase the relative proportion of glucose taken up by parasites and thereby worsen the clinical condition.


Subject(s)
Erythrocytes/parasitology , Monosaccharide Transport Proteins/genetics , Plasmodium falciparum/genetics , Protozoan Proteins , Amino Acid Sequence , Animals , Cloning, Molecular , Female , Fluorescent Antibody Technique , Hexoses/metabolism , Molecular Sequence Data , Monosaccharide Transport Proteins/chemistry , Monosaccharide Transport Proteins/metabolism , Plasmodium falciparum/metabolism , Protein Conformation , RNA, Messenger/genetics , Sequence Homology, Amino Acid , Xenopus laevis
4.
Exp Parasitol ; 90(2): 181-8, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9769248

ABSTRACT

The expression of purine-specific nucleoside and base transporters of Crithidia luciliae has been demonstrated in Xenopus laevis oocytes. Poly(A)+-mRNA from C. luciliae, cultured in either purine-replete or purine-starved conditions, was microinjected into X. laevis oocytes. For "purine-replete" mRNA, expression of adenosine and hypoxanthine uptake in microinjected X. laevis oocytes was increased on average 9- and 3-fold above water-injected controls, respectively. Expression of adenosine and hypoxanthine uptake in oocytes microinjected with "purine-starved" mRNA was 8 and 3-fold above water-injected controls, respectively. Substrate competition indicated an adenosine/deoxyadenosine transporter and a separate base transporter specific for hypoxanthine. In contrast to C. luciliae in vivo, where the level of activity of adenosine and hypoxanthine transport was regulated by the level of purines in the medium, the heterologous expression of these transporters (from both purine replete and deplete cultures) in X. laevis oocytes was independent of the extracellular purine concentration. These results may suggest that the presence of specific transporter message is independent of the extracellular purine content, indicating that the regulation of activation and expression of these transporters in C. luciliae may not be under transcriptional control.


Subject(s)
Adenosine/metabolism , Carrier Proteins/biosynthesis , Crithidia/metabolism , Hypoxanthine/metabolism , Membrane Proteins/biosynthesis , Animals , Carrier Proteins/genetics , Crithidia/genetics , Deoxyglucose/metabolism , Gene Expression , Membrane Proteins/genetics , Microinjections , Monosaccharide Transport Proteins/biosynthesis , Monosaccharide Transport Proteins/genetics , Monosaccharide Transport Proteins/metabolism , Nucleoside Transport Proteins , Oocytes/metabolism , RNA, Messenger/metabolism , Xenopus laevis
5.
Mol Biochem Parasitol ; 93(1): 81-9, 1998 May 15.
Article in English | MEDLINE | ID: mdl-9662030

ABSTRACT

When the malarial parasite Plasmodium falciparum multiplies in erythrocytes it dramatically increases uptake of essential metabolic precursors (nucleosides, nucleobases and glucose) and export of lactic acid by undefined mechanisms. The first evidence is provided here, by a detailed study in Xenopus laevis oocytes, that several specific nutrient transporters are the product of P. falciparum genes. We report the expression of nucleoside, nucleobase, hexose and monocarboxylate transport systems in Xenopus oocytes when injected with mRNA isolated from asexual stages of developing P. falciparum parasites. Their properties are distinct from transport events occurring at the infected erythrocyte membrane or the electrophysiologically identified channel localised to the parasitophorous vacuolar membrane. These novel transporters are substrate-specific and stereoselective, and represent a key regulatory step in the acquisition and export of metabolites by intraerythrocytic P. falciparum.


Subject(s)
Carrier Proteins/biosynthesis , Plasmodium falciparum/genetics , Plasmodium falciparum/metabolism , Adenosine/metabolism , Animals , Biological Transport , Deoxyglucose/metabolism , Erythrocytes/parasitology , Gene Expression , Hypoxanthine/metabolism , Models, Biological , Oocytes , Permeability , RNA, Messenger/genetics , RNA, Protozoan/genetics , Substrate Specificity , Xenopus laevis
7.
Am J Surg ; 169(1): 120-5, 1995 Jan.
Article in English | MEDLINE | ID: mdl-7817980

ABSTRACT

Small intestinal epithelium digests and absorbs nutrients. Crypt stem cell transplantation can generate neomucosa with normal morphology, but the digestive and absorptive capacities of this neomucosa are unknown. This study evaluates stem cell induced neomucosal brush border digestive enzyme activity and nutrient transport function. Rodent small intestinal epithelial stem cells were isolated by enzymatic digestion, then grafted to inbred recipients. Grafts were retrieved at 25 days, and apical brush border membrane vesicles prepared for quantitative assays. Neomucosal lactase, sucrase, aminopeptidase N, and alkaline phosphatase activity was determined by incubation with enzyme specific substrate. Neomucosal sodium dependent D-glucose transport was evaluated by incubation with D-[U-14C] glucose. Comparative assays were performed in age-matched control intestine. Neomucosal digestive enzyme activities and D-glucose transport were all similar in neomucosa and control small intestine.


Subject(s)
Hematopoietic Stem Cell Transplantation , Intestinal Mucosa/physiology , Intestine, Small/physiology , Animals , Animals, Newborn , Biological Transport , Epithelium , Intestinal Absorption , Intestinal Mucosa/ultrastructure , Microvilli , Rats , Rats, Inbred Strains
8.
Biochim Biophys Acta ; 1226(2): 232-6, 1994 May 25.
Article in English | MEDLINE | ID: mdl-7911330

ABSTRACT

Transport of the carcinogen benzo[a]pyrene in apical membrane vesicles (AMV) from normal human intestine, was investigated. Benzo[a]pyrene transport was found in AMV throughout the small intestine, but was greatest in colon. Evidence suggesting involvement of P-Glycoprotein (P-Gp), included (1) comparable transport of P-Gp substrate doxorubicin, (2) transport stimulation by ATP and (3) transport suppression by the P-Gp inhibitor, verapamil.


Subject(s)
Benzo(a)pyrene/metabolism , Colon/metabolism , Intestine, Small/metabolism , ATP Binding Cassette Transporter, Subfamily B, Member 1 , Adenosine Triphosphate/pharmacology , Adult , Aged , Alkaline Phosphatase/analysis , Aminopeptidases/analysis , Biological Transport, Active/drug effects , CD13 Antigens , Carrier Proteins/metabolism , Cell Membrane/metabolism , Colon/ultrastructure , Doxorubicin/metabolism , Female , Humans , Intestine, Small/ultrastructure , Male , Membrane Glycoproteins/metabolism , Middle Aged , Verapamil/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...